EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review

Doris Nnenna Amuji, Suleiman Zakari, Ayomikun Joshua Pirisola, Olubanke Olujoke Ogunlana, Emeka E J Iweala

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2025.101089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Doris Nnenna Amuji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun State, Nigeria; Covenant Applied Informatics and Commun…. Hauptthemen laut MEDLINE: Breast Neoplasms, Proto-Oncogene Proteins c-met, Drug Resistance, Neoplasm, Ubiquitin Thiolesterase. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Covenant University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance remains a serious challenge in breast cancer, and abnormal c-mesenchymal epithelial transition factor (c-Met) receptor tyrosine kinase (RTK) activation contributes to therapeutic resistance in many. Ubiquitin-specific peptidase 8 (USP8) has emerged as a modulator of RTK stability through deubiquitination and endosomal trafficking, and preclinical studies show that inhibition of USP8 speeds up ubiquitin-dependent degradation of RTKs, including c-Met and EGFR, suppresses PI3K/Akt and MAPK signaling, and reverses resistance phenotypes. In this review, we summarize mechanistic evidence for USP8 regulation of c-Met and related RTKs, explore preclinical studies that assess inhibition of USP8 as a strategy to sensitize RTK-driven tumors, and highlight translational limitations such as drug selectivity, toxicity, dosing, pharmacodynamics biomarkers, and patient selection that must be addressed prior to a clinical trial in breast cancer. While the therapeutic targeting of USP8 is promising, direct validation in breast cancer models and the development of robust pharmacodynamic markers and inhibitors that are clinically graded remain crucial next phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProto-Oncogene Proteins c-metDrug Resistance, NeoplasmUbiquitin ThiolesteraseEndopeptidasesEndosomal Sorting Complexes Required for TransportAntineoplastic AgentsHumansFemaleAnimalsMolecular Targeted TherapySignal Transduction

Stichwörter der Autor:innen

Breast cancerTargeted therapyUsp8c-Met resistancedeubiquitination

Substanzen

Proto-Oncogene Proteins c-metUSP8 protein, humanUbiquitin ThiolesteraseEndopeptidasesEndosomal Sorting Complexes Required for TransportAntineoplastic AgentsMET protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun State, Nigeria; Covenant Applied Informatics and Communication - Africa Centre of Excellence (CApIC-ACE), Covenant University…

Förderung

  • Covenant University

Zitieren

APA

Amuji, D. N., Zakari, S., Pirisola, A. J., Ogunlana, O. O., & Iweala, E. E. J. (2026). Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101089

Vancouver

Amuji DN, Zakari S, Pirisola AJ, Ogunlana OO, Iweala EEJ. Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2025.101089

BibTeX
@article{Amuji2026,
  author = {Amuji, Doris Nnenna and Zakari, Suleiman and Pirisola, Ayomikun Joshua and Ogunlana, Olubanke Olujoke and Iweala, Emeka E J},
  title = {Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2025.101089}
}
Kostenlos starten →